Every story tagged Biotechnology, curated for CIOs and IT leaders — ranked by source credibility, engagement, and freshness.
2 stories · open in the command center
Colossal, a biotech startup backed by major VCs and intelligence agencies, is shifting its de-extinction narrative to emphasize practical conservation technologies with immediate real-world applications, including reproductive techniques and genetic biobanking for endangered species preservation. While the company's previous projects faced criticism for misleading claims and potentially diverting resources from existing conservation efforts, its latest work on reproductive harvesting technology and open-source genetic repositories demonstrates tangible value that could benefit broader conservation strategies. For IT leaders, this represents an emerging intersection of synthetic biology, data management, and biotech infrastructure that will require new capabilities in genomic data handling, security, and collaborative data sharing platforms.
Iku Bio has developed a revolutionary microfluidic bioreactor using printed circuit boards that dramatically reduces the cost and time of biologics manufacturing optimization from $20,000 to $8 per experimental lane while enabling real-time data collection and AI integration. This innovation fundamentally transforms cell culture research from a manual, time-consuming process to a high-throughput, data-rich operation that aligns biology with modern computational capabilities. For IT organizations, this represents a critical emerging domain where biotech enterprises will require sophisticated data infrastructure, analytics platforms, and AI/ML capabilities to process and leverage biological data at scale.